Inhibicion de la Angiogénesis en pTNEs - page 20

Sunitinib en

TNEs

G1/G2

Safety & QOL

ViniK A, et al. Targ Oncol 2016

–40

9 10

Cycle

Observed mean change in

global HRQoL

Sunitinib

Placebo

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,10,11,12,13,14,15,16,17,18,19 21,22,23,24,25,26,27,28,29,30,...36